Contact Us

Defective Medical Devices
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date when device was implanted :

Please describe any problems or injuries caused by the product:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Health Canada warns consumers not to use triaminic vapour patch due to potential health risks

May 30, 2006 | Health Canada

Health Canada is warning consumers not to use Triaminic Vapour Patch due to the serious adverse health effects that could result if the product is accidentally ingested by children.

Triaminic Vapour Patch contains camphor, eucalyptus oil and menthol. The reported side-effects from swallowing products containing camphor or eucalyptus oils vary from minor symptoms such as burning sensation in the mouth, headache, nausea and vomiting to more severe and life-threatening reactions such as seizures.

Health Canada is aware of one adverse reaction associated with the use of Triaminic Vapour Patch. The adverse reaction involved a child who had a seizure after chewing on the patch.

Triaminic Vapour Patch is advertised as a cough suppressant for children two years of age and older. The directions on the label indicate that the patch is to be applied to the throat or chest to allow the vapours to reach the nose and mouth. Once applied, the patch would be within close reach for a child to remove and ingest. An additional risk is the product's cherry scent, which could also lead a child to chew or swallow the patch.

The product is sold over the counter as a natural health product at pharmacies and retail outlets in Canada. A recall of the product will be initiated by the distributor. Consumers should discontinue use of this product and return it to the point of purchase.

Consumers who have used the product and have concerns about their health should contact their physicians or health care practitioner.

Consumers requiring more information about this advisory can contact Health Canada's public enquiries line at (613) 957-2991, or toll free at 1-866-225-0709.

To report a suspected adverse reaction with these or any other health product, please contact the Canadian Adverse Drug Reaction Monitoring Program (CADRMP) of Health Canada by one of the following methods:

Telephone: 866-234-2345
Facsimile: 866-678-6789

Products Directorate
Health Protection Building, Tunney's Pasture, AL 0701C
Ottawa, Ontario K1A 0K9
Email: cadrmp@hc-sc.gc.ca


Related articles Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo